# Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection

> **NCT03453281** · PHASE4 · COMPLETED · sponsor: **Indonesia University** · enrollment: 36 (actual)

## Conditions studied

- Diabetic Macular Edema
- Diabetic Retinopathy
- Clinically Significant Macular Edema

## Interventions

- **DRUG:** Aflibercept Injection [Eylea]

## Key facts

- **NCT ID:** NCT03453281
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-10
- **Primary completion:** 2018-04-09
- **Final completion:** 2018-05-18
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03453281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03453281, "Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03453281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*